James R Whittle
6PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 14, 2026
Patient-derived organoids and neurospheres recapitulate salient features of primary tumor heterogeneity.Zachery Moore, Claire Storey, Daniel V Brown
|Aug 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma.James R Whittle, Maria Vieito, Kristoffer Rohrberg
|Aug 21, 2025
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.Katharine J Drummond, Montana Spiteri, Sarah A Cain
|Aug 14, 2024
A perioperative study of Safusidenib in patients with IDH1-mutated glioma.Sarah A Cain, Monique Topp, Mark Rosenthal
|Jun 14, 2023
Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas.Arian Lasocki, Michael E Buckland, Tahlia Molinaro
|Aug 04, 2017
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.Delphine Merino, James R Whittle, François Vaillant
Pageof 1
Frequent Collaborators
3 joint publications
Katharine J Drummond
3 joint publications
Saskia Freytag
2 joint publications
Jia-Nan Gong
2 joint publications
Sarah A Best
1 joint publications
Oliver M Sieber
1 joint publications
François Vaillant
1 joint publications
Najoua Lalaoui
1 joint publications
David C S Huang
1 joint publications
Gordon K Smyth
1 joint publications
Jane E Visvader
